CVL-871
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CVL-871, covering 2026-03-11 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy [Phase 2]